4-Morpholinecarbonyl chloride → Methyl 1-(morpholin-4-ylcarbonyl)-5-[4-(trifluoromethyl)phenyl]piperidine-3-carboxylate
반응식
[F:1][C:2]([F:20])([F:19])[C:3]1[CH:8]=[CH:7][C:6]([CH:9]2[CH2:14][NH:13][CH2:12][CH:11]([C:15]([O:17][CH3:18])=[O:16])[CH2:10]2)=[CH:5][CH:4]=1.[N:21]1([C:27](Cl)=[O:28])[CH2:26][CH2:25][O:24][CH2:23][CH2:22]1>>[N:21]1([C:27]([N:13]2[CH2:14][CH:9]([C:6]3[CH:7]=[CH:8][C:3]([C:2]([F:19])([F:1])[F:20])=[CH:4][CH:5]=3)[CH2:10][CH:11]([C:15]([O:17][CH3:18])=[O:16])[CH2:12]2)=[O:28])[CH2:26][CH2:25][O:24][CH2:23][CH2:22]1참가 물질
3
실험 절차
According to General Method 3A, 9.25 g (32.2 mmol) of methyl 5-[4-(trifluoromethyl)phenyl]piperidine-3-carboxylate and 9.63 g (64.7 mmol) of morpholine-4-carbonyl chloride were reacted. This gave 16.3 g of crude product in 76% purity (LC-MS), which was converted without any further purifying operations.
후처리
- customwere reacted
- customany further purifying operations
출처 및 근거
- ORD 기록
- ord-204d007036154381a200884723d3bf00
- 출처 데이터셋
- uspto-grants-2011_12
- 특허 번호
- US08084469B2
반응 노트
불러오는 중…